The purpose of this Research Topic in Frontiers in Renal Pharmacology is to provide a collection of articles as a basis for training and education in renal pharmacology/pathophysiology, and its application to developing drugs for the treatment of kidney disease, both acute and chronic. We want to increase awareness of how developments in our understanding of renal (patho)physiology have the potential to improve the recognition and treatment of kidney disease, and how we can achieve successfully the transition from 'bench to bedside': What scientific and technological approaches, infrastructure and expertise this path from basic research findings to application in humans may require.
To that end we would like to receive general article submissions based on an author or authors expertise, interests and experience, giving examples of their particular journey and learnings in a more educational format. We are not seeking original research or in-depth review of a particular topic, but illustrative examples from renal physiology and pharmacology that may lead to new treatments.
We also seek articles from those more directly involved in drug development or pharmaceutical medicine to describe this process in more detail, its requirements and obstacles, and especially from those with experience of conducting first in human studies and larger clinical trials. Since many engaged in biological research do so with the ultimate goal of improving our knowledge and understanding of human physiology and pathophysiology, and improve the care provided to patients, the target audience is mainly those at an early stage of their scientific or clinical careers, and who have an interest in understanding kidney function and in how this knowledge can and should be applied.
The purpose of this Research Topic in Frontiers in Renal Pharmacology is to provide a collection of articles as a basis for training and education in renal pharmacology/pathophysiology, and its application to developing drugs for the treatment of kidney disease, both acute and chronic. We want to increase awareness of how developments in our understanding of renal (patho)physiology have the potential to improve the recognition and treatment of kidney disease, and how we can achieve successfully the transition from 'bench to bedside': What scientific and technological approaches, infrastructure and expertise this path from basic research findings to application in humans may require.
To that end we would like to receive general article submissions based on an author or authors expertise, interests and experience, giving examples of their particular journey and learnings in a more educational format. We are not seeking original research or in-depth review of a particular topic, but illustrative examples from renal physiology and pharmacology that may lead to new treatments.
We also seek articles from those more directly involved in drug development or pharmaceutical medicine to describe this process in more detail, its requirements and obstacles, and especially from those with experience of conducting first in human studies and larger clinical trials. Since many engaged in biological research do so with the ultimate goal of improving our knowledge and understanding of human physiology and pathophysiology, and improve the care provided to patients, the target audience is mainly those at an early stage of their scientific or clinical careers, and who have an interest in understanding kidney function and in how this knowledge can and should be applied.